A Krasucka-Kluźniak1. Show Affiliations » 1. Kliniki Gruźlicy i Chorób Płuc Instytutu Gruźlicy i Chorób Płuc.
Abstract
Mesh： See more » AnimalsAntitubercular Agents/pharmacologyAntitubercular Agents/therapeutic useAntitubercular Agents/toxicityCiprofloxacin/pharmacologyCiprofloxacin/therapeutic useCiprofloxacin/toxicityClofazimine/pharmacologyClofazimine/therapeutic useClofazimine/toxicityDrug EvaluationDrug Evaluation, PreclinicalHumansIn Vitro TechniquesMiceMycobacterium tuberculosis/drug effectsOfloxacin/pharmacologyOfloxacin/therapeutic useOfloxacin/toxicityRifabutinRifamycins/pharmacologyRifamycins/therapeutic useRifamycins/toxicityTuberculosis/drug therapyTuberculosis/microbiology
Substances： See more » Antitubercular AgentsRifamycinsRifabutinCiprofloxacinOfloxacinClofazimine
Year: 1990 PMID： 2168041
Source DB: PubMed Journal: Pneumonol Pol ISSN： 0376-4761